English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

4. Статистический бюллетень. Итоги всероссийской переписи населения 2010 года по Иркутской области. Иркутск: Иркутскстат, 2012. 5. Baatarkhuu O., Kim D.Y., Bat-Ireedui P., Han K.H. Current situation of hepatocellular carcinoma in Mongolia. Oncology. 2011, 81 Suppl 1: 148-151. 6. Babor T., Higgins-Biddle J.C., Saunders J.B., Monteiro M.G. AUDIT — The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care (2nd edn). Geneva: World Health Organization, 2001. 7. But D.Y., Lai C.L., Yuen M.F. Natural history of hepatitis-related hepatocellular carcinoma. World J. Gastroentelol. 2008, 14(11): 1652-1656. 8. Cole P., Morrison A.S. Basic issues in population screening for cancer. J. Natl. Cancer Inst. 1980, 64(5): 1263-1272. 9. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J. Hepatol. 2018; 69(1): 182-236. 10. Global hepatitis report 2017. Geneva: World Health Organization, 2017. 11. Parikh N.D., Fu S., Rao H. et al. Risk assessment of hepatocellular carcinoma in patients with hepatitis C in China and the USA. Dig. Dis. Sci. 2017, 62(11): 3243-3253. 12. Raza S.A., Clifford G.M., Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. British J.Cancer. 2007, 96(7): 1127-1134. 13. Trad D., Bibani N., Sabbah M. et al. Known new and emerging risk factors of hepatocellular carcinoma (review). Presse Med. 2017, 46(11): 1000-1007. 14. Tsatsralt-Od B., Takahashi M., Nishizawa T. et al. Inoue J., Ulaankhuu D., Okamoto H. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia. Arch. Virol. 2005, 150(12): 2513-2528. 15. Yapali S., Tosun N. Epidemiology and viral risk factors for hepatocellular carcinoma in the Eastern Mediterranean countries. Hepatoma Res. 2018, 4: 24-34.

PRECLINICAL STUDIES OF RECOMBINANT PSEUDOMONAS VACCINE